$5.18
0.204.02%
Last update: Oct 27, 4:00 AM
Cingulate Inc (CING) Stock Price, Quote, News & History
CINGNASDAQ
Cingulate slipped in premarket trading as investors weighed its wider quarterly loss against a fresh patent win and new funding to support its ADHD drug launch...
You can purchase shares of Cingulate (NASDAQ:CING) through any online brokerage.
Other companies in Cingulate’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Cingulate has a consensus price target of $21.25.
The stock price for Cingulate (NASDAQ: CING) is $5.1 last updated October 27, 2026 at 4:00 AM EDT.
There are no upcoming dividends for Cingulate.
Cingulate does not have any upcoming earnings scheduled.
There is no upcoming split for Cingulate.
Cingulate is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an...
